Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11025438 | International Journal of Infectious Diseases | 2018 | 9 Pages |
Abstract
In light of laboratory evidence, a quarter of patients suspected of TBLA had an alternative diagnosis, highlighting its importance in avoiding over-treatment and diagnostic delays in malignancy. Although sensitivity is poor, the demonstration of drug resistance by both GeneXpert and AFB culture represents a useful tool to guide treatment.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Samreen Sarfaraz, Sundus Iftikhar, Yousuf Memon, Naila Zahir, Fivzia Farooq Hereker, Naseem Salahuddin,